Gastroscopy is procedure in which flexible tube recognised as gastroscope is used to detect internal structure or the parts of stomach, esophagus, and the small intestine. The procedure is used to inspect the lining of gastrointestinal tract. The procedure can be done to acquire a biopsy to identify diseases such as coeliac or to perform test for helicobacter pylori. Helicobacter pylori is bacterium which is common cause of the gastric ulcers and duodenal.
Major drivers for growth of market across the globe are growing the prevalence of the gastric diseases, rising geriatric population, and the rising demand for advanced procedures and early diagnosis. Growth of market is restricted by high cost and possibility of developing infection through use of gastroscopes.
The growing prevalence of the gastric diseases has augmented investment made in the research by private and public organizations. This will supplementary lead to increase in demand for the procedure. According to article published in World Journal of Gastroenterology (WJG), in 2017, peptic ulcer affects almost 4 million people yearly with projected incidence rate of the 1.5 to 3.0%. According to the No Stomach for Cancer, Inc., in the year 2015, gastric cancer was third common cause of the deaths due to the malignancy and caused almost 723,000 deaths global. Thus, growing occurrences of cancers will further propel the growth of the market.Segment Overview
The global market has been divided into type, and end user. By type, market has been divided into standard, transnasal, therapeutic, and dual-channel gastroscopes. By end user, market has been categorised as diagnostic labs, hospitals and clinics, ambulatory surgical centers, and others.Regional Overview
The global market, based on region, is separated into the North America, Asia-Pacific, Europe, and the Middle East and Africa. In North America, market is undergoing tremendous growth owing to the increasing adoption of the new technologies for the detection of stomach ulcer, gastric cancer, and other gastrointestinal diseases and the rising prevalence of the digestive conditions such as dysphagia and dyspepsia. According to study conducted by National Foundation for the Swallowing Disorder, almost 15 million adults have suffered from dysphagia in the year 2016. Thus, market in the North America is expected to be largest during assessment period.
The European market for expected to be second-largest during forecast period. In Europe, prevalence of the disorders such as esophageal cancer, Barrett's esophagus, and inflammatory bowel disease is increasing, especially in geriatric population. According to Cancer Research UK, there were over 6680 new cases of the stomach cancer in UK in 2014, such factors are projected to boost growth of market.Competitor overview
In September 2017, the Stryker Corporation has acquired NOVADAQ Technologies Inc, aiming to increase product portfolio of the imaging technology.
In June 2017, the Boston Scientific Corporation launched the Alair bronchial thermoplastic treatment in India.
In January 2017, the PENTAX Medical (Hoya Group) has acquired C2 Therapeutics with the aim to expand interventional endoscopy products. With the acquisition, company aims to support its position in global gastroscopes market.Key Players
- Boston Scientific Corporation
- Cogentix Medical
- Fujifilm Holdings Corporation
- Olympus Corporation
- PENTAX MEDICAL
- Endomed Systems
- KARL STORZ GmbH & Co. KG.
- SonoScape Medical Corp.
- Perkin Elmer
- Standard Gastroscopes
- Therapeutic Gastroscopes
- Transnasal Gastroscopes
- Dual-Channel Gastroscopes
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diagnostic Labs
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Rest of LAMEA